Company / Return on Equity (ROE)
CorMedix Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
40.2%
FY2025
5-year range
-66.1% / 40.2%
FY2021-FY2025
Trend
+289.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) changed +290% YoY in FY2025, a notable deviation from the 9-year average annual change of +6%.
Based on SEC 10-K filings.
40.2% in FY2025 with a 5-year CAGR of +109.7%.
Improved from -66.1% to 40.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +85.1pp
- 5-Year Change
- +109.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 289.9% year-over-year.
- Lowest return on equity (roe) in the period was in FY2019.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 40.2% | +289.9% |
| FY2024 | -21.2% | +67.9% |
| FY2023 | -66.1% | -47.1% |
| FY2022 | -44.9% | +9.8% |
| FY2021 | -49.8% | +28.3% |
| FY2020 | -69.5% | +87.2% |
| FY2019 | -543.7% | -18.5% |
| FY2018 | -458.9% | -231.7% |
| FY2017 | -138.3% | -130.0% |
| FY2016 | -60.1% | -12.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026